Cyclic strain alters the expression and release of angiogenic factors by human tendon cells

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Mousavizadeh, Rouhollah ^a   Khosravi, Shahram ^a   Behzad, Hayedeh ^a   McCormack, Robert G ^a   Duronio, Vincent ^a   Scott, Alex ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; PEPTIDES AND PROTEINS; PROTEIN ANGPTL4; SPHINGOSINE KINASE 1; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C; ANGIOGENIC FACTOR; ANGIOPOIETIN; ANGPTL4 PROTEIN, HUMAN; PHOSPHOTRANSFERASE; PRIMER DNA; PTGS2 PROTEIN, HUMAN; SPHINGOSINE KINASE;

ADULT; ANGIOGENESIS; ANGPTL4 GENE; ARTICLE; CASE REPORT; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; COX 2 GENE; FEMALE; FGF 2 GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MECHANICAL STRESS; PROTEIN SECRETION; SPHK1 GENE; TENDINITIS; TENDON; TENOCYTE; TGF ALPHA GENE; VEGF A GENE; VEGF C GENE; ANALYSIS OF VARIANCE; BIOMECHANICS; CUMULATIVE TRAUMA DISORDER; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; STIMULATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETINS; BIOMECHANICAL PHENOMENA; BLOTTING, WESTERN; CUMULATIVE TRAUMA DISORDERS; CYCLOOXYGENASE 2; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PHYSICAL STIMULATION; STRESS, PHYSIOLOGICAL; TENDONS; TRANSFORMING GROWTH FACTOR ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84901262048     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097356     Document Type: Article

References (26)

1. Lewis JS, Raza SA, Pilcher J, Heron C, Poloniecki JD (2009) The prevalence of neovascularity in patients clinically diagnosed with rotator cuff tendinopathy. BMC Musculoskelet Disord 10: 163.
2. Seitz AL, McClure PW, Finucane S, Boardman ND 3rd, Michener LA (2011) Mechanisms of rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clinical biomechanics 26: 1-12.
3. Mehta S, Gimbel JA, Soslowsky LJ (2003) Etiologic and pathogenetic factors for rotator cuff tendinopathy. Clin Sports Med 22: 791-812. (Pubitemid 37175578)
4. Arnoczky SP, Lavagnino M, Egerbacher M (2007) The mechanobiological aetiopathogenesis of tendinopathy: is it the over-stimulation or the understimulation of tendon cells? International journal of experimental pathology 88: 217-226. (Pubitemid 47256309)
5. Blevins FT (1997) Rotator cuff pathology in athletes. Sports medicine 24: 205-220.
6. Matthews TJ, Hand GC, Rees JL, Athanasou NA, Carr AJ (2006) Pathology of the torn rotator cuff tendon. Reduction in potential for repair as tear size increases. The Journal of bone and joint surgery British volume 88: 489-495.
7. Lakemeier S, Reichelt JJ, Patzer T, Fuchs-Winkelmann S, Paletta JR, et al. (2010) The association between retraction of the torn rotator cuff and increasing expression of hypoxia inducible factor 1alpha and vascular endothelial growth factor expression: an immunohistological study. BMC musculoskeletal disorders 11: 230.
8. Divani K, Chan O, Padhiar N, Twycross-Lewis R, Maffulli N, et al. (2010) Site of maximum neovascularisation correlates with the site of pain in recalcitrant mid-tendon Achilles tendinopathy. Manual therapy 15: 463-468.
9. Gotoh M, Hamada K, Yamakawa H, Inoue A, Fukuda H (1988) Increased substance P in subacromial bursa and shoulder pain in rotator cuff diseases. J Orthop Res 16: 618-621.
10. Mendias CL, Gumucio JP, Bakhurin KI, Lynch EB, Brooks SV (2012) Physiological loading of tendons induces scleraxis expression in epitenon fibroblasts. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 30: 606-612.
11. Al-Sadi O, Schulze-Tanzil G, Kohl B, Lohan A, Lemke M, et al. (2011) Tenocytes, pro-inflammatory cytokines and leukocytes: a relationship? Muscles, ligaments and tendons journal 1: 68-76.
12. Almekinders LC, Banes AJ, Ballenger CA (1993) Effects of repetitive motion on human fibroblasts. Med Sci Sports Exerc 25: 603-607. (Pubitemid 23138079)
13. Jones ER, Jones GC, Legerlotz K, Riley GP (2013) Cyclical strain modulates metalloprotease and matrix gene expression in human tenocytes via activation of TGFbeta. Biochimica et biophysica acta 1833: 2596-2607.
14. Wang JH, Jia F, Yang G, Yang S, Campbell BH, et al. (2003) Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connective tissue research 44: 128-133. (Pubitemid 37304544)
15. Backman LJ, Fong G, Andersson G, Scott A, Danielson P (2011) Substance P is a mechanoresponsive, autocrine regulator of human tenocyte proliferation. PloS one 6: e27209.
16. Scott A, Khan KM, Duronio V (2005) IGF-I activates PKB and prevents anoxic apoptosis in Achilles tendon cells. J Orthop Res 23: 1219-1225. (Pubitemid 41245451)
17. Karsan A, Cornejo CJ, Winn RK, Schwartz BR, Way W, et al. (1998) Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium. The Journal of clinical investigation 101: 2438-2445. (Pubitemid 28270438)
18. Arnaoutova I, Kleinman HK (2010) In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nature protocols 5: 628-635.
19. Zudaire E, Gambardella L, Kurcz C, Vermeren S (2011) A computational tool for quantitative analysis of vascular networks. PloS one 6: e27385.
20. Hojabrpour P, Waissbluth I, Ghaffari M, Cox ME, Duronio V (2012) CaMKII-gamma mediates phosphorylation of BAD at Ser170 to regulate cytokinedependent survival and proliferation. The Biochemical journal 442: 139-149.
21. Savitskaya YA, Izaguirre A, Sierra L, Perez F, Cruz F, et al. (2011) Effect of angiogenesis-related cytokines on rotator cuff disease: the search for sensitive biomarkers of early tendon degeneration. Clinical medicine insights Arthritis and musculoskeletal disorders 4: 43-53.
22. Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ, et al. (2011) ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters. Blood 118: 3990-4002.
23. Le Jan S, Amy C, Cazes A, Monnot C, Lamande N, et al. (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. The American journal of pathology 162: 1521-1528. (Pubitemid 36512834)
24. Gealekman O, Burkart A, Chouinard M, Nicoloro SM, Straubhaar J, et al. (2008) Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. American journal of physiology Endocrinology and metabolism 295: E1056-1064.
25. Morisada T, Kubota Y, Urano T, Suda T, Oike Y (2006) Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium: journal of endothelial cell research 13: 71-79.
26. Hato T, Tabata M, Oike Y (2008) The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends in cardiovascular medicine 18: 6-14.